Free tool
FAERS Monitor: Purinethol
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 009053 or its brand name (Purinethol, Mercaptopurine). Reports on generic versions are filed under their own applications.
Reports
17,433
Serious
15,076
86% of reports
Hospitalization
7,819
Death reported
1,975
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- febrile neutropenia1,932
- pyrexia1,192
- off label use1,150
- drug ineffective1,108
- nausea800
- vomiting761
- diarrhoea705
- abdominal pain703
- neutropenia612
- headache603
- fatigue556
- pneumonia529
- crohn^s disease521
- sepsis503
- anaemia475
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 192 |
| 2005 | 151 |
| 2006 | 163 |
| 2007 | 223 |
| 2008 | 272 |
| 2009 | 478 |
| 2010 | 554 |
| 2011 | 643 |
| 2012 | 830 |
| 2013 | 465 |
| 2014 | 765 |
| 2015 | 780 |
| 2016 | 865 |
| 2017 | 1,062 |
| 2018 | 1,186 |
| 2019 | 1,229 |
| 2020 | 1,146 |
| 2021 | 1,273 |
| 2022 | 1,402 |
| 2023 | 1,221 |
| 2024 | 1,135 |
| 2025 | 831 |
| 2026 | 567 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,036,726 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| febrile neutropeniaSignal | 1,932 | 36.2 | 34.6 | 64,303 |
| sepsisSignal | 503 | 5.5 | 5.0 | 1,830 |
| neutropeniaSignal | 612 | 5.5 | 5.0 | 2,224 |
| pyrexiaSignal | 1,192 | 4.2 | 3.9 | 2,904 |
| abdominal painSignal | 703 | 3.7 | 3.4 | 1,363 |
| anaemiaSignal | 475 | 3.0 | 2.8 | 640 |
| pneumonia | 529 | 2.0 | 1.8 | 256 |
| vomiting | 761 | 2.0 | 1.8 | 361 |
| off label use | 1,150 | 1.6 | 1.5 | 258 |
| diarrhoea | 705 | 1.3 | 1.2 | 55 |
| nausea | 800 | 1.2 | 1.1 | 33 |
| headache | 603 | 1.2 | 1.1 | 14 |
| drug ineffective | 1,108 | 1.0 | 1.0 | 0 |
| fatigue | 556 | 0.9 | 0.8 | 13 |
| crohn^s disease | 521 | 0.0 | 0.0 | 627,509 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.